We hypothesize that another pathway by which the mechanisms of action of AtDCS in early-stage AD is that AtDCS may directly affect production and degradation of Aβ, thereby attenuating neurotoxicity and reducing GFAP activation. This evidence concerns the gene GFAP and Alzheimer disease.